BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 27130315)

  • 1. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17():47. PubMed ID: 27130315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
    Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
    Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
    PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine and its metabolites in Alzheimer's disease patients.
    Gulaj E; Pawlak K; Bien B; Pawlak D
    Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma.
    Möller M; Du Preez JL; Harvey BH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():121-9. PubMed ID: 22608808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis.
    Curto M; Lionetto L; Fazio F; Corigliano V; Comparelli A; Ferracuti S; Simmaco M; Nicoletti F; Baldessarini RJ
    Schizophr Res; 2019 Jun; 208():465-466. PubMed ID: 30837204
    [No Abstract]   [Full Text] [Related]  

  • 8. Tryptophan and Kynurenine Metabolites: Are They Related to Depression?
    Pompili M; Lionetto L; Curto M; Forte A; Erbuto D; Montebovi F; Seretti ME; Berardelli I; Serafini G; Innamorati M; Amore M; Baldessarini RJ; Girardi P; Simmaco M
    Neuropsychobiology; 2019; 77(1):23-28. PubMed ID: 30110684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan catabolism and vitamin B-6 status are affected by gender and lifestyle factors in healthy young adults.
    Deac OM; Mills JL; Shane B; Midttun Ø; Ueland PM; Brosnan JT; Brosnan ME; Laird E; Gibney ER; Fan R; Wang Y; Brody LC; Molloy AM
    J Nutr; 2015 Apr; 145(4):701-7. PubMed ID: 25833774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of tryptophan, kynurenine, kynurenic acid, xanthurenic acid and 5-hydroxytryptamine in human plasma by LC-MS/MS and its application to acute myocardial infarction monitoring.
    Tong Q; Song J; Yang G; Fan L; Xiong W; Fang J
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain.
    Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B
    Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A validated liquid chromatography-high resolution-tandem mass spectrometry method for the simultaneous quantitation of tryptophan, kynurenine, kynurenic acid, and quinolinic acid in human plasma.
    Arnhard K; Pitterl F; Sperner-Unterweger B; Fuchs D; Koal T; Oberacher H
    Electrophoresis; 2018 May; 39(9-10):1171-1180. PubMed ID: 29327354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
    Zhang Z; Zhang M; Luo Y; Ni X; Lu H; Wen Y; Fan N
    Hum Psychopharmacol; 2020 Jul; 35(4):e2738. PubMed ID: 32352599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure.
    Pawlak D; Tankiewicz A; Mysliwiec P; Buczko W
    Nephron; 2002 Mar; 90(3):328-35. PubMed ID: 11867954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
    Heyes MP; Saito K; Devinsky O; Nadi NS
    Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in kynurenine metabolites in the gray and white matter of the dorsolateral prefrontal cortex of individuals affected by schizophrenia.
    Antenucci N; D'Errico G; Fazio F; Nicoletti F; Bruno V; Battaglia G
    Schizophrenia (Heidelb); 2024 Feb; 10(1):27. PubMed ID: 38413629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.